BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25665021)

  • 1. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering.
    Suurmond J; Dorjée AL; Knol EF; Huizinga TW; Toes RE
    Clin Exp Allergy; 2015 Apr; 45(4):788-96. PubMed ID: 25665021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human basophils by combined toll-like receptor- and FcεRI-triggering can promote Th2 skewing of naive T helper cells.
    Suurmond J; Stoop JN; Rivellese F; Bakker AM; Huizinga TW; Toes RE
    Eur J Immunol; 2014 Feb; 44(2):386-96. PubMed ID: 24122358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies.
    Suurmond J; Rivellese F; Dorjée AL; Bakker AM; Rombouts YJ; Rispens T; Wolbink G; Zaldumbide A; Hoeben RC; Huizinga TW; Toes RE
    Ann Rheum Dis; 2015 Oct; 74(10):1915-23. PubMed ID: 24818634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands.
    Takenaka H; Ushio H; Niyonsaba F; Jayawardana ST; Hajime S; Ikeda S; Ogawa H; Okumura K
    Biochem Biophys Res Commun; 2010 Jan; 391(1):471-6. PubMed ID: 19914211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoglobulin E-Toll-like receptor network.
    Novak N; Bieber T; Peng WM
    Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteria and viruses modulate FcεRI-dependent mast cell activity].
    Słodka A; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():164-73. PubMed ID: 23475493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils.
    Sumbayev VV; Yasinska I; Oniku AE; Streatfield CL; Gibbs BF
    PLoS One; 2012; 7(3):e34259. PubMed ID: 22470546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling enhances FcεRI-mediated cytokine production by mast cells through direct and indirect mechanisms.
    Nakano N; Nishiyama C; Yagita H; Hara M; Motomura Y; Kubo M; Okumura K; Ogawa H
    J Immunol; 2015 May; 194(9):4535-44. PubMed ID: 25821223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
    Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
    Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2.
    Yoshioka M; Fukuishi N; Iriguchi S; Ohsaki K; Yamanobe H; Inukai A; Kurihara D; Imajo N; Yasui Y; Matsui N; Tsujita T; Ishii A; Seya T; Takahama M; Akagi M
    J Allergy Clin Immunol; 2007 Aug; 120(2):452-61. PubMed ID: 17481719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells.
    Qiao H; Andrade MV; Lisboa FA; Morgan K; Beaven MA
    Blood; 2006 Jan; 107(2):610-8. PubMed ID: 16174756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites.
    Platzer B; Baker K; Vera MP; Singer K; Panduro M; Lexmond WS; Turner D; Vargas SO; Kinet JP; Maurer D; Baron RM; Blumberg RS; Fiebiger E
    Mucosal Immunol; 2015 May; 8(3):516-32. PubMed ID: 25227985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-sensitization in vivo enhances mast cell-induced inflammatory responses and supports innate immunity.
    Salinas E; Quintanar JL; Ramírez-Celis NA; Quintanar-Stephano A
    Immunol Lett; 2009 Dec; 127(1):48-54. PubMed ID: 19733592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcεRI or FcαRI on mast cells in mouse allergic asthma.
    Hong GU; Lim JY; Kim NG; Shin JH; Ro JY
    Eur J Pharmacol; 2015 May; 754():199-210. PubMed ID: 25704619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice.
    Kanagaratham C; El Ansari YS; Sallis BF; Hollister BA; Lewis OL; Minnicozzi SC; Oyoshi MK; Rosen R; Nurko S; Fiebiger E; Oettgen HC
    J Allergy Clin Immunol; 2020 Oct; 146(4):884-893.e5. PubMed ID: 32194041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide suppresses IgE-mast cell-mediated reactions.
    Wang N; McKell M; Dang A; Yamani A; Waggoner L; Vanoni S; Noah T; Wu D; Kordowski A; Köhl J; Hoebe K; Divanovic S; Hogan SP
    Clin Exp Allergy; 2017 Dec; 47(12):1574-1585. PubMed ID: 28833704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
    Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
    Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.